Evidence map›Paper›PMID 30068705›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Local Phototherapy Synergizes with Immunoadjuvant for Treatment of Pancreatic Cancer through Induced Immunogenic Tumor Vaccine.

Feifan Zhou, Jingxuan Yang, Yuqing Zhang, Mingyang Liu, Mark L Lang, Min Li, Wei R Chen

Abstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Immune modulations of the tumor microenvironment in response to phototherapy.Journal of innovative optical health sciences · 2023
    Article
  17. Hybrid Nanomaterials for Cancer Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  18. CuInternational journal of nanomedicine · 2023
    Article
  19. Article
  20. Advances and Prospects in the Treatment of Pancreatic Cancer.International journal of nanomedicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Feifan Zhou *Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen, China.
Jingxuan Yang *Department of Medicine, Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Yuqing ZhangDepartment of Medicine, Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Mingyang LiuDepartment of Medicine, Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Mark L LangDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Min LiDepartment of Medicine, Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. wchen@uco.edu Min-Li@ouhsc.edu.
Wei R ChenKey Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen, China. wchen@uco.edu Min-Li@ouhsc.edu.
University of Oklahoma Health Sciences Center · USUniversity of Central Oklahoma · US

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michael S. Businelle · 2018 to 2026
$27.1M
Prognostic Biomarkers for ZIP4-mediated Cachexia in Pancreatic CancerR01CA203108 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI LI, MIN, LI, YI-PING · 2016 to 2020
$2.7M
ZIP4 is a Novel Molecular Target in Human Pancreatic CancerR01CA186338 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI FERNANDEZ-ZAPICO, MARTIN ERNESTO, LI, MIN · 2015 to 2019
$1.7M
Mechanistic study on synergistic photo-immunological effects of laser immunotherapy for metastatic cancersR01CA205348 · NCI · UNIVERSITY OF OKLAHOMA · PI CHEN, WEI R. · 2017 to 2021
$1.5M
Role of Dietary Zinc Transporter ZIP4 in Pancreatic CancerR01CA138701 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LI, MIN · 2010 to 2015
$1.5M
A Novel Multifunctional Bionanoprobe-Based Phototherapy for Metastatic CancersR21EB015509 · NIBIB · UNIVERSITY OF CENTRAL OKLAHOMA · PI CHEN, WEI R. · 2013 to 2014
$350k
NCI NIH HHS P30 CA225520NCI NIH HHS R01 CA138701NCI NIH HHS R01 CA186338NCI NIH HHS R01 CA203108NCI NIH HHS R01 CA205348NIBIB NIH HHS R21 EB015509
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunogenicity, VaccinePhotochemotherapyAdjuvants, ImmunologicAnimalsAntigens, NeoplasmCancer VaccinesCell Line, TumorCell SurvivalCombined Modality TherapyDisease Models, AnimalHumansLymphocytes, Tumor-InfiltratingMicePancreatic NeoplasmsTumor BurdenXenograft Model Antitumor AssaysAdjuvants, ImmunologicAntigens, NeoplasmCancer Vaccines

Identifiers

PMID30068705
PMCPMC6214772
OpenAlexW2886103417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.